跳至主要内容
临床试验/NCT07636694
NCT07636694招募中不适用

Effects of Concurrent and Consecutive Repetitive Transcranial Magnetic Stimulation (rTMS) and Cognitive Bias Modification (CBM)

The University of Hong Kong1 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2025年2月24日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
180
试验地点
1

研究概览

简要总结

The goal of this study is to learn whether combining repetitive transcranial magnetic stimulation (rTMS) with a computerized behavioral intervention (imagery cognitive bias modification, CBM-I) reduces negative interpretation bias and mild-to-moderate depressive symptoms. The study will also examine neural changes in the dorsolateral prefrontal cortex (DLPFC) and whether timing of interventions affects outcomes.

The main questions it aims to answer are:

Does active TMS reduce negative interpretation bias and depressive symptoms more than sham TMS? Is delivering CBM-I concurrently with TMS more effective than delivering it consecutively (separate sessions) at reducing negative bias and depressive symptoms? Do combined rTMS + CBM-I approaches produce greater neural changes and improved cognitive control over self-referential interpretation than controls? Researchers will compare active TMS versus sham TMS, and concurrent versus consecutive delivery of CBM-I, to test effects on negative bias and depressive symptoms.

Participants will:

Receive either active rTMS or sham TMS targeting the DLPFC Complete imagery CBM-I sessions either concurrently with TMS or in separate (consecutive) sessions Undergo assessments of negative interpretation bias, depressive symptoms, and neural measures before and after the intervention

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • Aged 18 years or above
  • Right-handed
  • Normal or corrected hearing and vision
  • Obtained primary education or above
  • Able to fluently read and understand Chinese
  • Beck's Depression Inventory-II (BDI-II) score ranging from 14-28

排除标准

  • History of severe physical disease, brain organic diseases, and neurological disorders (e.g., dementia, brain injury, stroke, epilepsy, Parkinson's disease)
  • History of substance use/ dependence/ withdrawal
  • Participants with intellectual disability based on IQ scores
  • Participants with contraindications for rTMS such as foreign metal bodies, implant devices (cochlear implants) or history (personal or family) of seizure
  • Participants who are not suitable to be scanned by magnetic resonance imaging (MRI) machine (e.g., claustrophobic, pregnant, metal in the body, hearing aids)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Richard Liu

Mr Richard Liu - HKU-KCL Joint PhD Programme PhD Candidate

The University of Hong Kong

研究点 (1)

Loading locations...

相似试验